Annual report pursuant to Section 13 and 15(d)

Restructuring Charges

Restructuring Charges

12 Months Ended

Dec. 31, 2013

Restructuring and Related Activities [Abstract]

13.

Restructuring Charges

In September 2012, the Company approved and publicly announced a business plan to close the Company’s SymbioTec office in Germany and shift operations to the Company’s office in the UK. The Company treated all costs incurred related to this closing as restructuring charges. The closing was expected to drive cost savings and leverage potential synergies from the SymbioTec acquisition.

The expenses incurred include employee severance and facility closure charges. The Company incurred total expenses of approximately $112,000 related to SymbioTec restructuring activities, which was recorded in the line item administrative expenses in the Company’s statement of operations. The following table sets forth the costs incurred during the year ended December 31, 2012:


	Year ended December 31,
	2012
Facility closure expenses	$	13,000
Employee termination expenses		99,000
Total restructuring charges	$	112,000

All costs related to the SymbioTec restructuring activities were completed as of December 31, 2012.